catechol has been researched along with Hyperlipemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miyawaki, M | 1 |
| Sano, H | 1 |
| Imbe, H | 1 |
| Fujisawa, R | 1 |
| Tanimoto, K | 1 |
| Terasaki, J | 1 |
| Maeda-Yamamoto, M | 1 |
| Tachibana, H | 1 |
| Hanafusa, T | 1 |
| Imagawa, A | 1 |
1 trial available for catechol and Hyperlipemia
| Article | Year |
|---|---|
"Benifuuki" Extract Reduces Serum Levels of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Ligands Containing Apolipoprotein B: A Double-Blind Placebo-Controlled Randomized Trial.
Topics: Aged; Apolipoprotein B-100; Biomarkers; Camellia sinensis; Catechols; Dietary Supplements; Double-Bl | 2018 |